Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Confocal Visible/nir Photoacoustic Microscopy of Tumors with Structural, Functional, and Nanoprobe Contrasts

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Photoacoustic Imaging Application in Tumor Diagnosis and Treatment Monitoring

Imaging of Tumor Hyper-Metabolism with Near-Infrared Fluorescence Contrast Agents

Apoferritin-Engineered Nanoprobe for Tumor-Targeted Triple-NIR Imaging and Phototherapy

Dual-Stimulus Responsive Near-Infrared Reversible Ratiometric Fluorescent and Photoacoustic Probe for in Vivo Tumor Imaging.

Tumor-specific enhanced NIR-II photoacoustic imaging via photothermal and low-pH coactivated AuNR@PNIPAM-VAA nanogel

A Non-Peptide Chymotrypsin Activatable Probe for 3D-Photoacoustic and NIR Fluorogenic Imaging of Deep Tumor

Fluorescence Nanoprobe Imaging Tumor By Sensing The Acidic Microenvironment

An NIR Fluorescent/photoacoustic Dual-Mode Probe of NADPH for Tumor Imaging

A Tumor-targetable NIR Probe with Photoaffinity Crosslinking Characteristics for Enhanced Imaging-Guided Cancer Phototherapy

Application of Nanoprobes in Photoacoustic Cancer Imaging

Dextran based pH-sensitive near-infrared nanoprobe for in vivo differential-absorption dual-wavelength photoacoustic imaging of tumors

Photoacoustic microscopy for real-time monitoring of near-infrared optical absorbers inside biological tissue

A Self-Calibrating Fluorescent-Photoacoustic Integrated Probe Enables Fast Visualizing Pancreatic Cancer and Imaging-Guided Tumor Surgery

SNR-enhanced Fiber-Laser Ultrasound Sensors for Photoacoustic Tomography

Photoacoustic and Thermoacoustic Imaging Application in Cancer Early Detection and Treatment Monitoring

Progress of Photoacoustic Imaging Combined with Targeted Photoacoustic Contrast Agents in Tumor Molecular Imaging.

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

Ph-Sensitive and Biodegradable Charge-Transfer Nanocomplex for Second Near-Infrared Photoacoustic Tumor Imaging

A NIR‐II Photoacoustic Probe for High Spatial Quantitative Imaging of Tumor Nitric Oxide in Vivo